Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

VIA Pharmaceuticals, Inc. has announced the results of two Phase 2 studies of its lead drug, VIA-2291.

10 Nov 2008

Initiative by world-recognized specialists in heart disease and diabetes to reduce residual vascular risk

Residual Risk Reduction Initiative (R3i) Calls for Action to Reduce the Lipid-Related Residual Vascular Risk Unaddressed by Current Standards of Care in Millions of Patients With Heart Disease and Diabetes.

10 Nov 2008

Heart attack prevention within three months after hospitalization significantly averted future attacks

Despite substantial progress in the diagnosis and treatment of heart attack patients, prevention of recurrent heart attacks continues to be a major clinical challenge.

10 Nov 2008

High levels of high-sensitivity C-reactive protein found to be new risk factor for cardiovascular disease

A team of international researchers - including scientists from the McGill University Health Centre (MUHC) and McGill University - have discovered that having high levels of particular protein puts patients at increased risk of developing cardiovascular disease.

10 Nov 2008

Rising triglyceride levels may be behind rising rates of obesity

A new 30-year analysis of the National Health and Nutrition Examination Survey (NHANES) database conducted by the National Lipid Association (NLA) indicates that while Americans are doing a better job of managing LDL or "bad" cholesterol, the percentage of adults with high triglycerides, a blood fat linked to heart disease, has doubled, leaving many people at risk for potentially life-threatening events such as heart attack or stroke.

10 Nov 2008

Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes

Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type 2 diabetes, according to a new study in JAMA.

10 Nov 2008

Heart failure hospitalization rates rise among nation's seniors

Heart failure is reaching epidemic levels among seniors in the United States, according to research presented at the American Heart Association's Scientific Sessions 2008.

10 Nov 2008

Flu shots may reduce risk of blood clots forming in veins

Flu shots may reduce the risk of blood clots forming in veins by 26 percent, according to research presented at the American Heart Association's Scientific Sessions 2008.

10 Nov 2008

Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

New data from the JUPITER study demonstrated that Crestor (rosuvastatin calcium) 20 mg significantly reduced major cardiovascular (CV) events (defined in this study as the combined risk of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes) by a dramatic 44% compared to placebo (p<0.001) among men and women with elevated hsCRP but low to normal cholesterol levels.

10 Nov 2008

Study compares survival following different heart disease treatments in patients with ESRD

For patients with end stage renal disease (ESRD) on dialysis who also must be treated for heart disease, stents provide the best one-year survival compared with other revascularization treatments, but bypass surgery provides the best long-term survival, according to a paper being presented at the American Society of Nephrology's 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania.

7 Nov 2008

Metabolic syndrome found in quarter of the U.S. workforce

The combination of health risks known as metabolic syndrome affects slightly less than a quarter of the U.S. workforce and is linked to increased absenteeism and poorer health status, reports a study in the October Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

7 Nov 2008

For African Americans with hypertensive nephrosclerosis, end stage renal disease risks exceed risk of death from heart disease

For most patients with chronic kidney disease (CKD), the risk of experiencing a cardiovascular related death is greater than the risk of progressing to end-stage renal disease (ESRD).

7 Nov 2008

FDA approves Ranexa for the treatment of chronic angina

CV Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved a new, first line indication for Ranexa(R) (ranolazine extended-release tablets) for the treatment of chronic angina.

7 Nov 2008

ERSD, heart disease and African-Americans with hypertensive nephrosclerosis

For most patients with chronic kidney disease (CKD), the risk of experiencing a cardiovascular related death is greater than the risk of progressing to end-stage renal disease (ESRD).

7 Nov 2008

New clinical guidelines on prevention of cardiovascular disease and diabetes in patients at highest risk

The Endocrine Society has released a new clinical practice guideline for the primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk.

7 Nov 2008

Contaminants in human milk

An overview of studies on environmental pollutants in human milk has found that not breastfeeding an infant typically poses more of a threat than does exposure to any of the chemical agents measured in human milk, as reported in the 11th Annual Children’s Health Issue of Environmental Health Perspectives (EHP).

6 Nov 2008

Enhancing quality and safety of care for patients across Europe

This discussion derives from the ongoing debate on the directive proposal for the application of cross-border healthcare patients' rights presented by the European Commission (EC) in July this year.

5 Nov 2008

Folate, vitamin B6 and B12 do not appear to affect cancer risk

A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according to a study in the November 5 issue of JAMA, the Journal of the American Medical Association.

5 Nov 2008

Experts available to comment on risk of sudden cardiac death in 30 days following a heart attack

A new study in the November 5th 2008 issue of JAMA finds that during the first month after a heart attack, patients may have an increased risk for sudden cardiac death.

5 Nov 2008

Systems biology and glycomics used to study human inflammatory diseases

An innovative systems biology approach to understanding the carbohydrate structures in cells is leading to new ways to understand how inflammatory illnesses and cardiovascular disease develop in humans. The work was described in two recent publications by University at Buffalo chemical engineers.

28 Oct 2008

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

Initiative by world-recognized specialists in heart disease and diabetes to reduce residual vascular risk

Heart attack prevention within three months after hospitalization significantly averted future attacks

High levels of high-sensitivity C-reactive protein found to be new risk factor for cardiovascular disease

Rising triglyceride levels may be behind rising rates of obesity

Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes

Heart failure hospitalization rates rise among nation's seniors

Flu shots may reduce risk of blood clots forming in veins

Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

Study compares survival following different heart disease treatments in patients with ESRD

Metabolic syndrome found in quarter of the U.S. workforce

For African Americans with hypertensive nephrosclerosis, end stage renal disease risks exceed risk of death from heart disease

FDA approves Ranexa for the treatment of chronic angina

ERSD, heart disease and African-Americans with hypertensive nephrosclerosis

New clinical guidelines on prevention of cardiovascular disease and diabetes in patients at highest risk

Contaminants in human milk

Enhancing quality and safety of care for patients across Europe

Folate, vitamin B6 and B12 do not appear to affect cancer risk

Experts available to comment on risk of sudden cardiac death in 30 days following a heart attack

Systems biology and glycomics used to study human inflammatory diseases

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Newsletters you may be interested in